The Microcarriers Market size was estimated USD 1.52 billion in 2023 and is expected to reach USD 3.68 billion by 2031 at a CAGR of 11.7% during the forecast period of 2024-2031.
Microcarriers operate as a support matrix for adherent cell growth. These microcarriers are used in a bioreactor to help in cell proliferation. Pharmaceutical businesses and research institutes are increasingly relying on microcarrier dry powder and related equipment to conduct rigorous R&D operations. The growing global disease burden has increased R&D activity in order to provide therapeutically effective drugs/vaccines, resulting in a demand for microcarrier goods.
.png)
DRIVERS
Growing interest in cell-based vaccines
Population expansion, climate change, and more human-animal contact have all increased the risk of new viral epidemics. For example, influenza and COVID-19 have shown to be unpredictable and recurring phenomena that impose a large economic and social burden. The WHO reported 117.33 million cases of COVID-19 worldwide as of March 10, 2021, including 2.61 million deaths. The rising prevalence of infectious diseases, as well as the growing threat of pandemics, are predicted to drive global vaccination demand.
RESTRAIN
Cell biology research is expensive
Cell biology entails a significant amount of research and development (R&D) on new medicines such as stem cell and gene therapies. The equipment, media, reagents, and other products associated with research must be of the highest quality to provide accurate results The cost of cell biology research has risen significantly as a result of the growing necessity to maintain high quality standards (by the use of high-grade materials) and comply with regulatory body norms. As a result, with inadequate funding, many academic institutions and small firms are unable to pursue cell biology research. Because microcarriers are used in stem cell biology, this factor is likely to limit market expansion. Moreover, because microcarriers adhere to cells, the cells must be collected, which increases downstream processing costs. As a result, the expansion of the microcarrier market is projected to be limited.
OPPORTUNITY
Increasing monoclonal antibody synthesis is increasing.
The increased popularity of targeted treatment options for diseases such as cancer, autoimmune and inflammatory illnesses is driving up demand for monoclonal antibodies internationally. Because antibodies are given in high concentrations, the need for mAbs is also significant.
CHALLENGES
The unavailability of low-cost serum-free media, as well as microcarrier-cell detachment
Although the Russian pharmaceutical industry was not subject to Western sanctions imposed following the invasion of Ukraine, domestic players experienced significant difficulties in importing active ingredients. According to the local analyst firm RNC Pharma, Russian medicine makers rely on imported raw ingredients to the tune of 80%. China and India account for more than two-thirds of all imports. Moreover, while these countries continue to serve the Russian Federation, supply systems in these areas have also failed.
IMPACT OF ONGOING RECESSION
The global pandemic of the new coronavirus (COVID-19) caused tremendous volatility, uncertainty, and economic disruption in several of the nations where we operate, including the United States, Mexico, Canada, Poland, Germany, Hungary, and China. We believe the pandemic impacted customer demand for our products as well as customer preferences regarding product mix and distribution channels, and there is significant uncertainty regarding general economic conditions as we emerge from the pandemic, including rising inflation, supply chain disruptions, and a possible national or global recession.
By Consumable
Media & Reagents
Microcarrier Bead
Collagen Coated Beads
Cationic Beads
Protein Coated Beads
Untreated Beads
Others
In 2023, microcarrier bead segment is expected to held the highest market share of 65.2% during the forecast period due to the constant development of microcarrier beads during cell culture adds to the market's highest revenue generating. Increased cell biology research, rising demand for regenerative therapies and biopharmaceuticals, and the availability of a variety of microcarrier beads that can be used for a variety of reasons have all contributed to the significant market expansion.
By Application
Biopharmaceutical Production
Vaccine Production
Therapeutic Production
Regenerative Medicine
In 2023, the biopharmaceutical Production segment is expected to dominate the market growth of 73.8% during the forecast period Because of the rising frequency of cancer, infectious diseases, and genetic problems, there is a greater need for safe and effective medicines and therapies. Biopharmaceutical businesses are expanding their capacity and product offerings to satisfy rising demand. For instance, in August 2022, Celltrion Inc., a Korea-based healthcare business, announced that its bevacizumab biosimilar, Vegzelma, has been approved by the European Commission for the treatment of certain forms of cancer. With the approval of its third biosimilar, the business has expanded its oncology treatment range for usage in Europe.
Furthermore, increased therapeutic biopharmaceutical usage and regulatory backing are driving the microcarriers market. For example, the US FDA has authorized 39 biosimilars till September 2022. These approvals have demonstrated that safe and effective biosimilars penetrated market and improved the access to care by offering multiple medication options at potentially lower costs.
By End User
Pharmaceutical & Biotechnology Companies
Contract Research Organizations & Contract Manufacturing Organizations
Academic & Research Institutes
.png)
In 2023, the pharmaceutical & biotechnology companies & CROs segment is expected to dominate the market growth of 73.8% during the forecast period to due to multiple drug research initiatives, the rising cell therapy business, greater R&D investments, and favorable government laws are all driving the expansion of this market. Furthermore, increased knowledge of the benefits of cell-based products is pushing biologics manufacturing by these enterprises, resulting in global development of capabilities. For example, Thermo Fisher Scientific, Inc. announced in August 2022 that it had enlarged its facility in Grand Island, New York. The USD 77 million expansion boosts the company's capacity to generate cell culture media for the production of vaccines and biologics.
North America held a significant market share of over 41.8% in 2023 due to rising chronic and infectious illness cases, increased knowledge of personalized medicines, improved healthcare infrastructure and reimbursement models, the presence of important market participants, and intensive R&D activities have all contributed to the region's rise. Furthermore, regulatory support for biopharmaceuticals and regenerative medicines is propelling innovative cell-based therapeutics to market. Because of current clinical success rates and the product pipeline, the US FDA forecasts that by 2025, it will be approving 10 to 20 cell and gene therapy items per year.
Asia-Pacific is witness to expand fastest CAGR rate during the forecast period owing to multiple research settings in the region are driven by government funds for vaccine manufacturing and low operating and labor expenses. Furthermore, the Asia Pacific area is driven by domestic biologics demand as well as expanding economies, and it also has the greatest elderly population. Furthermore, in this region, numerous local Asian and international corporations are establishing a number of the world's new bioprocessing facilities.
REGIONAL COVERAGE
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
The major key players are Thermo Fisher Scientific, Inc., Danaher Corporation,Merck KGaA, Sartorius AG, Medtronic, Bio-Rad Laboratories, Inc.,Corning Incorporated, HiMedia Laboratories Pvt. Ltd., Fujitsu Ltd., Microcarrier Corporation, Qualcomm,denovoMATRIX GmbH and Others.
denovoMATRIX GmbH, in May 2022 denovoMATRIX GmbH, a cell and gene therapy manufacturing firm based in Germany, has launched a new product called beadMATRIX. The new product is a unique microcarrier bead for 3D MSC culture that allows for high-quality and rapid stem cell proliferation.
Microcarrier Corporation, in february 2022, Microcarrier Corporation and Fujitsu Ltd. announced the signing of a formal agreement in which Fujitsu will purchase Microcarrier. The acquisition is estimated to be worth $4.2 billion.
In April 2022, Microcarrier Corporation and IBM signed a formal deal under which IBM will acquire Microcarrier for $4.4 billion.
In June 2022, Qualcomm and Microcarrier Corporation signed a definitive deal for Qualcomm to acquire Microcarrier for $4.5 billion.
| Report Attributes | Details |
| Market Size in 2023 | US$ 1.52 Billion |
| Market Size by 2031 | US$ 3.68 Billion |
| CAGR | CAGR of 11.7 % From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Consumables (Media & Reagents, Microcarrier Beads) • By Application (Biopharmaceutical Production, Regenerative Medicine) • By End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, Academic & Research Institutes) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | Thermo Fisher Scientific, Inc., Danaher Corporation,Merck KGaA, Sartorius AG, Medtronic, Bio-Rad Laboratories, Inc.,Corning Incorporated, HiMedia Laboratories Pvt. Ltd., Fujitsu Ltd., Microcarrier Corporation, Qualcomm,denovoMATRIX GmbH |
| Key Drivers | • Growing interest in cell-based vaccines |
| Market Challenges | • The unavailability of low-cost serum-free media, as well as microcarrier-cell detachment |
Ans: Microcarrier beads segment dominated the microcarriers market with a share of 65.2% in 2023.
Ans: Microcarriers Market is anticipated to expand by 11.7% from 2024 to 2031.
Ans: The growth rate of microcarriers market is expected to grow USD 3.68 billion by 2031.
Ans: Microcarriers Market size was valued at USD 1.52 billion in 2023.
Ans: Growing interest in cell-based vaccines.
TABLE OF CONTENTS
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Industry Flowchart
3. Research Methodology
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
5. Impact Analysis
5.1 Impact of Russia-Ukraine Crisis
5.2 Impact of Economic Slowdown on Major Countries
5.2.1 Introduction
5.2.2 United States
5.2.3 Canada
5.2.4 Germany
5.2.5 France
5.2.6 UK
5.2.7 China
5.2.8 Japan
5.2.9 South Korea
5.2.10 India
6. Value Chain Analysis
7. Porter’s 5 Forces Model
8. Pest Analysis
9. Microcarriers Market Segmentation, By Consumables
9.1 Introduction
9.3 Media & Reagents
9.4 Microcarrier Beads
9.4.1 Collagen Coated Beads
9.4.2 Cationic Beads
9.4.3 Protein Coated Beads
9.4.4 Untreated Beads
9.4.5 Others
10. Microcarriers Market Segmentation, By Application
10.2 Trend Analysis
10.3 Biopharmaceutical Consumablesion
10.3.1 Vaccine Consumablesion
10.3.2 Therapeutic Consumablesion
10.4 Regenerative Medicine
11. Microcarriers Market Segmentation, By End user
11.1 Introduction
11.3 Pharmaceutical and BioApplication Companies
11.4 Contract Research Organizations & Contract Manufacturing Organization
11.5 Academic and Research Institutes
12. Regional Analysis
12.1 Introduction
12.2 North America
12.2.1 Trend Analysis
12.2.2 North America Microcarriers Market by Country
12.2.3 North America Microcarriers Market By Consumables
12.2.4 North America Microcarriers Market By Application
12.2.5 North America Microcarriers Market By End user
12.2.6 USA
12.2.6.1 USA Microcarriers Market By Consumables
12.2.6.2 USA Microcarriers Market By Application
12.2.6.3 USA Microcarriers Market By End user
12.2.7 Canada
12.2.7.1 Canada Microcarriers Market By Consumables
12.2.7.2 Canada Microcarriers Market By Application
12.2.7.3 Canada Microcarriers Market By End user
12.2.8 Mexico
12.2.8.1 Mexico Microcarriers Market By Consumables
12.2.8.2 Mexico Microcarriers Market By Application
12.2.8.3 Mexico Microcarriers Market By End user
12.3 Europe
12.3.1 Trend Analysis
12.3.2 Eastern Europe
12.3.2.1 Eastern Europe Microcarriers Market by Country
12.3.2.2 Eastern Europe Microcarriers Market By Consumables
12.3.2.3 Eastern Europe Microcarriers Market By Application
12.3.2.4 Eastern Europe Microcarriers Market By End user
12.3.2.5 Poland
12.3.2.5.1 Poland Microcarriers Market By Consumables
12.3.2.5.2 Poland Microcarriers Market By Application
12.3.2.5.3 Poland Microcarriers Market By End user
12.3.2.6 Romania
12.3.2.6.1 Romania Microcarriers Market By Consumables
12.3.2.6.2 Romania Microcarriers Market By Application
12.3.2.6.4 Romania Microcarriers Market By End user
12.3.2.7 Hungary
12.3.2.7.1 Hungary Microcarriers Market By Consumables
12.3.2.7.2 Hungary Microcarriers Market By Application
12.3.2.7.3 Hungary Microcarriers Market By End user
12.3.2.8 Turkey
12.3.2.8.1 Turkey Microcarriers Market By Consumables
12.3.2.8.2 Turkey Microcarriers Market By Application
12.3.2.8.3 Turkey Microcarriers Market By End user
12.3.2.9 Rest of Eastern Europe
12.3.2.9.1 Rest of Eastern Europe Microcarriers Market By Consumables
12.3.2.9.2 Rest of Eastern Europe Microcarriers Market By Application
12.3.2.9.3 Rest of Eastern Europe Microcarriers Market By End user
12.3.3 Western Europe
12.3.3.1 Western Europe Microcarriers Market by Country
12.3.3.2 Western Europe Microcarriers Market By Consumables
12.3.3.3 Western Europe Microcarriers Market By Application
12.3.3.4 Western Europe Microcarriers Market By End user
12.3.3.5 Germany
12.3.3.5.1 Germany Microcarriers Market By Consumables
12.3.3.5.2 Germany Microcarriers Market By Application
12.3.3.5.3 Germany Microcarriers Market By End user
12.3.3.6 France
12.3.3.6.1 France Microcarriers Market By Consumables
12.3.3.6.2 France Microcarriers Market By Application
12.3.3.6.3 France Microcarriers Market By End user
12.3.3.7 UK
12.3.3.7.1 UK Microcarriers Market By Consumables
12.3.3.7.2 UK Microcarriers Market By Application
12.3.3.7.3 UK Microcarriers Market By End user
12.3.3.8 Italy
12.3.3.8.1 Italy Microcarriers Market By Consumables
12.3.3.8.2 Italy Microcarriers Market By Application
12.3.3.8.3 Italy Microcarriers Market By End user
12.3.3.9 Spain
12.3.3.9.1 Spain Microcarriers Market By Consumables
12.3.3.9.2 Spain Microcarriers Market By Application
12.3.3.9.3 Spain Microcarriers Market By End user
12.3.3.10 Netherlands
12.3.3.10.1 Netherlands Microcarriers Market By Consumables
12.3.3.10.2 Netherlands Microcarriers Market By Application
12.3.3.10.3 Netherlands Microcarriers Market By End user
12.3.3.11 Switzerland
12.3.3.11.1 Switzerland Microcarriers Market By Consumables
12.3.3.11.2 Switzerland Microcarriers Market By Application
12.3.3.11.3 Switzerland Microcarriers Market By End user
12.3.3.1.12 Austria
12.3.3.12.1 Austria Microcarriers Market By Consumables
12.3.3.12.2 Austria Microcarriers Market By Application
12.3.3.12.3 Austria Microcarriers Market By End user
12.3.3.13 Rest of Western Europe
12.3.3.13.1 Rest of Western Europe Microcarriers Market By Consumables
12.3.3.13.2 Rest of Western Europe Microcarriers Market By Application
12.3.3.13.3 Rest of Western Europe Microcarriers Market By End user
12.4 Asia-Pacific
12.4.1 Trend Analysis
12.4.2 Asia-Pacific Microcarriers Market by Country
12.4.3 Asia-Pacific Microcarriers Market By Consumables
12.4.4 Asia-Pacific Microcarriers Market By Application
12.4.5 Asia-Pacific Microcarriers Market By End user
12.4.6 China
12.4.6.1 China Microcarriers Market By Consumables
12.4.6.2 China Microcarriers Market By Application
12.4.6.3 China Microcarriers Market By End user
12.4.7 India
12.4.7.1 India Microcarriers Market By Consumables
12.4.7.2 India Microcarriers Market By Application
12.4.7.3 India Microcarriers Market By End user
12.4.8 Japan
12.4.8.1 Japan Microcarriers Market By Consumables
12.4.8.2 Japan Microcarriers Market By Application
12.4.8.3 Japan Microcarriers Market By End user
12.4.9 South Korea
12.4.9.1 South Korea Microcarriers Market By Consumables
12.4.9.2 South Korea Microcarriers Market By Application
12.4.9.3 South Korea Microcarriers Market By End user
12.4.10 Vietnam
12.4.10.1 Vietnam Microcarriers Market By Consumables
12.4.10.2 Vietnam Microcarriers Market By Application
12.4.10.3 Vietnam Microcarriers Market By End user
12.4.11 Singapore
12.4.11.1 Singapore Microcarriers Market By Consumables
12.4.11.2 Singapore Microcarriers Market By Application
12.4.11.3 Singapore Microcarriers Market By End user
12.4.12 Australia
12.4.12.1 Australia Microcarriers Market By Consumables
12.4.12.2 Australia Microcarriers Market By Application
12.4.12.3 Australia Microcarriers Market By End user
12.4.13 Rest of Asia-Pacific
12.4.13.1 Rest of Asia-Pacific Microcarriers Market By Consumables
12.4.13.2 Rest of Asia-Pacific Microcarriers Market By Application
12.4.13.3 Rest of Asia-Pacific Microcarriers Market By End user
12.5 Middle East & Africa
12.5.1 Trend Analysis
12.5.2 Middle East
12.5.2.1 Middle East Microcarriers Market by Country
12.5.2.2 Middle East Microcarriers Market By Consumables
12.5.2.3 Middle East Microcarriers Market By Application
12.5.2.4 Middle East Microcarriers Market By End user
12.5.2.5 UAE
12.5.2.5.1 UAE Microcarriers Market By Consumables
12.5.2.5.2 UAE Microcarriers Market By Application
12.5.2.5.3 UAE Microcarriers Market By End user
12.5.2.6 Egypt
12.5.2.6.1 Egypt Microcarriers Market By Consumables
12.5.2.6.2 Egypt Microcarriers Market By Application
12.5.2.6.3 Egypt Microcarriers Market By End user
12.5.2.7 Saudi Arabia
12.5.2.7.1 Saudi Arabia Microcarriers Market By Consumables
12.5.2.7.2 Saudi Arabia Microcarriers Market By Application
12.5.2.7.3 Saudi Arabia Microcarriers Market By End user
12.5.2.8 Qatar
12.5.2.8.1 Qatar Microcarriers Market By Consumables
12.5.2.8.2 Qatar Microcarriers Market By Application
12.5.2.8.3 Qatar Microcarriers Market By End user
12.5.2.9 Rest of Middle East
12.5.2.9.1 Rest of Middle East Microcarriers Market By Consumables
12.5.2.9.2 Rest of Middle East Microcarriers Market By Application
12.5.2.9.3 Rest of Middle East Microcarriers Market By End user
12.5.3 Africa
12.5.3.1 Africa Microcarriers Market by Country
12.5.3.2 Africa Microcarriers Market By Consumables
12.5.3.3 Africa Microcarriers Market By Application
12.5.3.4 Africa Microcarriers Market By End user
12.5.3.5 Nigeria
12.5.3.5.1 Nigeria Microcarriers Market By Consumables
12.5.3.5.2 Nigeria Microcarriers Market By Application
12.5.3.5.3 Nigeria Microcarriers Market By End user
12.5.3.6 South Africa
12.5.3.6.1 South Africa Microcarriers Market By Consumables
12.5.3.6.2 South Africa Microcarriers Market By Application
12.5.3.6.3 South Africa Microcarriers Market By End user
12.5.3.7 Rest of Africa
12.5.3.7.1 Rest of Africa Microcarriers Market By Consumables
12.5.3.7.2 Rest of Africa Microcarriers Market By Application
12.5.3.7.3 Rest of Africa Microcarriers Market By End user
12.6 Latin America
12.6.1 Trend Analysis
12.6.2 Latin America Microcarriers Market by country
12.6.3 Latin America Microcarriers Market By Consumables
12.6.4 Latin America Microcarriers Market By Application
12.6.5 Latin America Microcarriers Market By End user
12.6.6 Brazil
12.6.6.1 Brazil Microcarriers Market By Consumables
12.6.6.2 Brazil Microcarriers Market By Application
12.6.6.3 Brazil Microcarriers Market By End user
12.6.7 Argentina
12.6.7.1 Argentina Microcarriers Market By Consumables
12.6.7.2 Argentina Microcarriers Market By Application
12.6.7.3 Argentina Microcarriers Market By End user
12.6.8 Colombia
12.6.8.1 Colombia Microcarriers Market By Consumables
12.6.8.2 Colombia Microcarriers Market By Application
12.6.8.3 Colombia Microcarriers Market By End user
12.6.9 Rest of Latin America
12.6.9.1 Rest of Latin America Microcarriers Market By Consumables
12.6.9.2 Rest of Latin America Microcarriers Market By Application
12.6.9.3 Rest of Latin America Microcarriers Market By End user
13. Company Profiles
13.1 Thermo Fisher Scientific, Inc.
13.1.1 Company Overview
13.1.2 Financial
13.1.3 Consumables/ Services Offered
13.1.4 SWOT Analysis
13.1.5 The SNS View
13.2 Danaher Corporation
13.2.1 Company Overview
13.2.2 Financial
13.2.3 Consumables / Services Offered
13.2.4 SWOT Analysis
13.2.5 The SNS View
13.3 Merck KGaA
13.3.1 Company Overview
13.3.2 Financial
13.3.3 Consumables / Services Offered
13.3.4 SWOT Analysis
13.3.5 The SNS View
13.4 Sartorius AG
13.4.1 Company Overview
13.4.2 Financial
13.4.3 Consumables / Services Offered
13.4.4 SWOT Analysis
13.4.5 The SNS View
13.5 Medtronic
13.5.1 Company Overview
13.5.2 Financial
13.5.3 Consumables/ Services Offered
13.5.4 SWOT Analysis
13.5.5 The SNS View
13.6 Bio-Rad Laboratories, Inc.
13.6.1 Company Overview
13.6.2 Financial
13.6.3 Consumables/ Services Offered
13.6.4 SWOT Analysis
13.6.5 The SNS View
13.7 Corning Incorporated
13.7.1 Company Overview
13.7.2 Financial
13.7.3 Consumables/ Services Offered
13.7.4 SWOT Analysis
13.7.5 The SNS View
13.8 HiMedia Laboratories Pvt. Ltd.
13.8.1 Company Overview
13.8.2 Financial
13.8.3 Consumables/ Services Offered
13.8.4 SWOT Analysis
13.8.5 The SNS View
13.9 Fujitsu Ltd.
13.9.1 Company Overview
13.9.2 Financial
13.9.3 Consumables/ Services Offered
13.9.4 SWOT Analysis
13.9.5 The SNS View
13.10 Microcarrier Corporation
13.10.1 Company Overview
13.10.2 Financial
13.10.3 Consumables/ Services Offered
13.10.4 SWOT Analysis
13.10.5 The SNS View
14. Competitive Landscape
14.1 Competitive Benchmarking
14.2 Market Share Analysis
14.3 Recent Developments
14.3.1 Industry News
14.3.2 Company News
14.3.3 Mergers & Acquisitions
15. Use Case and Best Practices
16. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Autoinjectors Market size was estimated USD 0.8 billion in 2022 and is expected to reach USD 2.3 billion by 2030 at a CAGR of 14.2% during the forecast period of 2023-2030.
The Wearable Medical Devices Market is expected to reach USD 210.66 billion by 2031, and its Size was valued at USD 33.8 billion in 2023, it grows at a CAGR of 25.7% over the forecast period 2024-2031.
In 2023, The Telerehabilitation Market size amounted to USD 4.90 Billion & is estimated to reach USD 13.60 Billion by 2031 and increase at a compound annual growth rate of 13.6% between 2024 and 2031.
Drug Delivery Systems Market was valued at USD 42.80 Billion in 2023 and is expected to reach USD 87.82 Billion By 2031 and grow at a CAGR of 9.4% over the forecast period of 2024-2031.
The Upstream Bioprocessing Market size was estimated USD 16.9 billion in 2022 and is expected to reach USD 58.1 billion by 2030 at a CAGR of 16.7% during the forecast period of 2023-2030.
The Degenerative Disc Disease Treatment Market size was valued at USD 30.32 billion in 2023 and is estimated to reach at USD 55.75 billion in 2031 and grow at a compound annual growth rate approx. CAGR of 7.91% predicted for the forecast period of 2024-20
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
